Quality of life in the long-term treatment and the role of second-generation antipsychotics

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F07%3A00000467" target="_blank" >RIV/00216208:11120/07:00000467 - isvavai.cz</a>

Alternative codes found

RIV/00023752:_____/07:00000652

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Quality of life in the long-term treatment and the role of second-generation antipsychotics

Original language description

Health-related quality of life (QoL) represents important measure of treatment outcome in mental disorders. Numerous studies indicate that QoL of people with schizophrenia and bipolar disorder is similar to that of patients with chronic physical conditions. It has been shown that schizophrenia patients can themselves reliably assess their QoL; in addition to the objec-tive scales various self-reporting instruments are ušed. Patients with bipolar disorder háve QoL consistently higher than patients with schizophrenia and similar to that found in people with unipolar depression. Quality of life can be negatively affected by drug-induced side-effects and subjective treatment response. The second-generation antipsychotics (SGA) háve superior efficacy on QoLověř classical antipsychotics in approximately half of the studies with schizophrenia; in the other half those groups are comparable. However, in none of the trials novel antipsychotics were inferior. All SGA (clozapine, olanzapine, risp

Czech name

Kvalita života při dlouhodobé léčbě a role antipsychotik druhé generace

Czech description

Health-related quality of life (QoL) reprezentuje důležité měření při léčbě psychických poruch. Četné studie indikují, že QoL lidí se schizofrenií a bipolární poruchou je podobné s pacienty s chronickým fyzickým onemocněním.

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FL - Psychiatry, sexology

OECD FORD branch

—

Project

—

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2007

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Neuroendocrinology Letters

ISSN

0172-780X

e-ISSN

—

Volume of the periodical

28

Issue of the periodical within the volume

Suppl. 1

Country of publishing house

SE - SWEDEN

Number of pages

17

Pages from-to

117-133

UT code for WoS article

—

EID of the result in the Scopus database

—